Association between apolipoprotein E genotype and Alzheimer disease in African American subjects.

BACKGROUND The association between Alzheimer disease (AD) and genotypes at the apolipoprotein E (APOE) locus has been confirmed in numerous populations worldwide, but appears to be inconsistent in African American subjects. OBJECTIVE To investigate the association between APOE genotypes and AD in elderly African American subjects. DESIGN Clinic-based, multicenter case-control study and a family study. PARTICIPANTS A total of 338 African American probands meeting criteria for probable or definite AD, 301 cognitively healthy, elderly unrelated control subjects (spouses and community volunteers), and 108 siblings of 88 AD probands. MAIN OUTCOME MEASURES Odds of AD according to APOE genotype. RESULTS Compared with individuals with the APOEepsilon3/epsilon3, the odds of having AD were significantly increased among those with 1 or more copies of the epsilon4 allele; the odds ratio (OR) for the epsilon3/epsilon4 genotype was 2.6 (95% confidence interval [CI], 1.8-3.7), and the OR for the epsilon4/epsilon4 genotype was 10.5 (95% CI, 5.1-21.8). These risks decreased substantially after 68 years of age. The risk for AD was lower among individuals with the epsilon2/epsilon3 genotype (OR, 0.41; 95% CI, 0.22-0.79). The patterns of association were similar in men and women. These results obtained from comparisons of unrelated AD patients and controls were bolstered by results of analysis of family data that showed preferential transmission of the epsilon4 allele to demented siblings (P<<.001) and of the epsilon2 allele to nondemented siblings (P=.005). CONCLUSIONS The presence of 1 or 2 epsilon4 alleles is a determinant of AD risk in African American subjects. The age-related risk for decline associated with the epsilon4 allele and the apparent protective effect of the epsilon2 allele are similar to patterns observed in white subjects.

[1]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[2]  B. Dubois,et al.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. , 1999, American journal of human genetics.

[3]  J. Growdon,et al.  Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study , 1996, Neurology.

[4]  N. Breslow,et al.  Estimation of multiple relative risk functions in matched case-control studies. , 1978, American journal of epidemiology.

[5]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[6]  A. Hofman,et al.  Genetic transmission of Alzheimer's disease among families in a Dutch population based study. , 1993, Journal of medical genetics.

[7]  K. Marder,et al.  The APOE- (cid:101) 4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 2001 .

[8]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[9]  N. Breslow,et al.  The analysis of case-control studies , 1980 .

[10]  J. Growdon,et al.  Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19 , 1993, The Lancet.

[11]  W. Tsai,et al.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. , 1996, American journal of human genetics.

[12]  O. Gureje,et al.  Lack of an association between apolipoprotein E ϵ4 and Alzheimer's disease in elderly nigerians , 1995 .

[13]  E. Roccella,et al.  Hypertension-related morbidity and mortality in the southeastern United States. , 1997, The American journal of the medical sciences.

[14]  Daniel Rabinowitz,et al.  A Unified Approach to Adjusting Association Tests for Population Admixture with Arbitrary Pedigree Structure and Arbitrary Missing Marker Information , 2000, Human Heredity.

[15]  A Hofman,et al.  Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. , 1998, Human molecular genetics.

[16]  B. Dubois,et al.  Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. , 1995, Human molecular genetics.

[17]  E M Wijsman,et al.  Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. , 1996, American journal of human genetics.

[18]  R. Katzman.,et al.  Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia , 1997, Neurology.

[19]  R. Green,et al.  Risk of dementia among white and African American relatives of patients with Alzheimer disease. , 2002, JAMA.

[20]  E. Oguni,et al.  Dose‐dependent association of apolipoprotein e allele ε4 with late‐onset, sporadic Alzheimer's disease , 1994 .

[21]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[22]  K. Marder,et al.  Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. , 2000, Archives of neurology.

[23]  P A Wolf,et al.  Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. , 1994, JAMA.

[24]  PhilipR. Wenham,et al.  Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.

[25]  G. Schellenberg,et al.  Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study. , 1996, Journal of clinical epidemiology.

[26]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[27]  K. Davis,et al.  Patterns of risk in first-degree relatives of patients with Alzheimer's disease. , 1994, Archives of general psychiatry.

[28]  R. Nitsch,et al.  High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. , 2000, American journal of human genetics.

[29]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[30]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[31]  P. S. St George-Hyslop,et al.  Alzheimer's disease , 1996, Neurology.

[32]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[33]  O. Gureje,et al.  Apolipoprotein E—associated risk for Alzheimer's disease in the African‐American population is genotype dependent , 1997, Annals of neurology.

[34]  L. Farrer.  GENETICS AND THE DEMENTIA PATIENT , 1997 .

[35]  J. Growdon,et al.  Interrater agreement for diagnosis of Alzheimer's disease , 1994, Neurology.

[36]  G. Schellenberg,et al.  Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans , 1995, Annals of neurology.

[37]  Y. Agid,et al.  Apolipoprotein E ϵ4 Allele and Familial Aggregation of Alzheimer Disease , 1998 .

[38]  J. Laragh,et al.  Essential hypertension: renin and aldosterone, heart attack and stroke. , 1972, The New England journal of medicine.

[39]  N M Laird,et al.  A discordant-sibship test for disequilibrium and linkage: no need for parental data. , 1998, American journal of human genetics.

[40]  N M Laird,et al.  Family-based tests of association in the presence of linkage. , 2000, American journal of human genetics.